The 2024 PM360 Pharma Choice Awards – App/Digital Bronze Winner

BrightInsight and CSL Behring

The Hizentra App

The Hizentra® app was developed to support patients transitioning from in-clinic treatment to at-home self-infusions of Hizentra and to stay compliant. We conducted interviews with patients and physicians to understand the challenges in moving to selfadministered infusions. The app was designed to help patients properly self-infuse and stay compliant by enabling patients to easily track infusions and infusion sites, set reminders, and record and share their infusion journal with their doctor.

BrightInsight TEAM MEMBERS:
Kimberly Berger Global Accounts Director
Gary Wirth Global VP, Customer Solutions
Anisha Gururaj Director, Clinical Launch Success & Data Strategy
Andrew Tucker Director, Solution Owner Team
Johnathan Do Staff Solution Owner
Gokul Kulkarni Staff Software Engineer
Subbu Sankarasubbu Senior Manager, Platform Engineering
Sarah Matthews Manager, Program Manager

CSL BEHRING TEAM MEMBERS:
Brian Johnson Senior Director, Customer Engagement
Cindy Blackburn Director, Digital Health
Soroush Abidi Senior Manager
Phanikrishna Karnati Associate Director, Global Commercial & IT
Dan McNulty Associate Product Manager for Hizentra
David White Director, Commercial IT Platforms

Ads

You May Also Like

2021 Pharma Choice Unbranded Gold Winner Mind+Matter, an Ashfield Health Company and Amylyx

Mind+Matter, an Ashfield Health Company and Amylyx Amylyx booth explores exciting new pathways and ...

2021 Pharma Choice Variety (Chat Tool) Silver Winner Intouch Group, Regeneron Pharmaceuticals, and Sanofi Genzyme

Intouch Group, Regeneron Pharmaceuticals, and Sanofi Genzyme DUPIXENT’s Industry-Leading Patient Chat Tool The DUPIXENT ...

2017 Pharma Choice Gold Professional Print Campaign

Dudnyk Flexion Therapeutics “Meet Your Match” The ZILRETTA launch campaign was developed to show ...